Skip to main content
. Author manuscript; available in PMC: 2008 Mar 11.
Published in final edited form as: Oncogene. 2007 Aug 13;27(7):1013–1018. doi: 10.1038/sj.onc.1210708

Table 1. Effect of the genotype of (a) Atm and (b) Blm on intestinal tumor multiplicity.

The approximate fold-increase refers to Atm−/− or Blmm3/m3 compared to the other two classes. 129/S6 (129).Blmm3/+ mice were a gift from Allan Bradley (Baylor College of Medicine, Houston, TX); 129.Atm+/− mice were purchased from The Jackson Laboratory (Bar Harbor, ME); 129.Lig4+/− mice were a gift from Frederick Alt (Harvard University, Boston, MA). All mice were backcrossed to B6 for at least 11 (Atm), 10 (Blm), or 5 (Lig4) generations. Mouse husbandry and dissection were performed as previously described (Haigis et al., 2002). All mice were dissected between 3 and 5 months of age except for irradiated mice, which became moribund at 2 months. Whole-body IR was delivered using a Mark I 137 Cs irradiator, model 30 (J L Shepard & Assoc., San Fernando, CA), as previously described (Luongo and Dove, 1996). It was noted that Atm−/−;Apc1638N/+ and Blmm3/m3;Apc1638N/+ mice, but no other genotypic combination, developed numerous desmoid fibromas which were not enumerated.

a   Atm+/+ Atm+/− Atm−/−  
  Loc. Tumor count, mean ± SD (incidence) N Tumor count, mean ± SD (incidence) N Tumor count, mean ± SD (incidence) N Fold Increase (95%CI)
B6.ApcMin/+ SI 31 ± 7 47 35 ± 12 49 67 ± 10 17 2.0 (1.8–2.3)*
LI 0.9 ± 1.5 (47%) 1.1 ± 1.3 (47%) 3.8 ± 3.7 (94%*) 4.6 (2.2–9.3)*
B6.ApcMin/+ +5.0Gy IR SI 280 ± 70 7 276 ± 54 12 267 ± 53 3 1.0 (0.7–1.3)
LI 7.7 ± 3.0 (100%) 10 ± 7.5 (100%) 22 ± 5.5 (100%) 2.4 (1.4–4.2)*
B6.Apc1638N/+ SI 1.4 ± 1.1 13 1.5 ± 1.0 21 26 ± 9.4 20 16 (11–22)*
LI 0 ± 0 (0%) 0 ± 0 (0%) 0.8 ± 0.8 (45%*) N/A*
 
b   Blm+/+ Blmm3/+ Blmm3/m3  
  Loc. Tumor count, mean ± SD (incidence) N Tumor count, mean ± SD (incidence) N Tumor count, mean ± SD (incidence) N ~Fold-increase (95%CI)
B6.ApcMin/+ SI 28 ± 12 9 25 ± 7 15 99 ± 16 4 3.8 (2.9–5.0)*
LI 0.1 ± 0.3 (11%) 0.4 ± 0.6 (33%) 1.3 ± 0.5 (100%) 4.3 (1.8–21)*
B6.Apc1638N/+ SI 1.8 ± 0.8 5 0.9 ± 1.1 8 6.2 ± 3.2 20 5.1 (2.8–10)*
LI 0 ± 0 (0%) 0 ± 0 (0%) 0.1 ± 0.2 (5%) N/A
*

p<0.05, Jonkheere-Terpstra Test or χ² test compared to controls

No significant difference

Bootstrap ratios comparing the homozygous knockouts to the combined heterozygotes and wildtypes; N/A, Not Applicable; SI, small intestine; LI, large intestine.

HHS Vulnerability Disclosure